Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,139 | -45,145 | -64,244 | -56,390 | -45,048 |
| Depreciation Amortization | 490 | 1,371 | 1,954 | 768 | -146 |
| Accounts payable and accrued liabilities | -990 | 656 | -276 | -845 | 1,314 |
| Other Working Capital | -27,821 | 27,590 | -5,571 | -3,444 | 574 |
| Other Operating Activity | 2,479 | 1,801 | 3,268 | 4,985 | 1,888 |
| Operating Cash Flow | $-10,703 | $-13,727 | $-64,869 | $-54,926 | $-41,418 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,188 | 9,485 | 69,940 | -41,486 | -33,430 |
| PPE Investments | 128 | -41 | -226 | -416 | -2,026 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 12,520 |
| Investing Cash Flow | $-1,060 | $9,444 | $69,714 | $-41,902 | $-22,936 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 754 | 1,626 |
| Debt Repayment | -353 | -762 | -909 | -1,133 | -1,033 |
| Common Stock Issued | 823 | 1,923 | 535 | 98,599 | 69,403 |
| Financing Cash Flow | $470 | $1,161 | $-374 | $98,220 | $69,996 |
| Exchange Rate Effect | 20 | 73 | -287 | 115 | 42 |
| Beginning Cash Position | 18,122 | 21,171 | 16,987 | 15,480 | 9,796 |
| End Cash Position | 6,849 | 18,122 | 21,171 | 16,987 | 15,480 |
| Net Cash Flow | $-11,273 | $-3,049 | $4,184 | $1,507 | $5,684 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,703 | -13,727 | -64,869 | -54,926 | -41,418 |
| Capital Expenditure | N/A | N/A | -226 | -416 | -2,026 |
| Free Cash Flow | -10,703 | -13,727 | -65,095 | -55,342 | -43,444 |